Indian pharma has signed $13bn+ of biosimilar deals in 18 months. Capital is no longer the bottleneck. Talent is. Hiring demand has tripled since 2023, and downstream leadership searches now take 7–9 months.
Our View: Pharma Talent can run a Biosimilar business, but not yet a Biosimilar plant.
Read the latest Native Talent Trends, with insights from
Koustubh Kanade,
Managing Partner,
Healthcare & Pharma.